+1 (845) 317-8489 [email protected]

Paper details:
A brief introduction of the molecule, antibody, protein or cell used as therapy.
A short description of the pathophysiology of the disease for which this treatment is approved.
The mechanism of action, any clinical trial outcome, and adverse reactions.
Supporting scientific literature. With a two page paper and a PowerPoint presentation. The antibody to research on is Tefibazumab